CompoAtlas

Ashwagandha et crinière de lion

Food supplement declared in France, decision dated 22 July 2026

Ashwagandha et crinière de lion (Bright Naturo) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: polysaccharides 325 mg per day, bêtaglucanes 60 mg per day, Hericium erinaceus 650 mg per day, Withania somnifera 600 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Bright Naturo
Food business operator placing the product on the market
Bright Naturo Lab SL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Sachet
Daily dose
1 sachet (2 gélules) par jour
Directions for use
Prendre 1 sachet (2 gélules) par jour avec de l’eau, de préférence au cours d’un repas.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Memory, Nervous system, Concentration

Declaration 371442, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Hericium erinaceusFruiting bodyOther dry extract650 mg
Withania somnifera (L.) DunalRootOther dry extract600 mg

Substances

NamePer day
polysaccharides325 mg
bêtaglucanes60 mg

Additives

E551, E470b, E341

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser comme substitut d’une alimentation variée et équilibrée ni d’un mode de vie sain. Ne pas dépasser la dose journalière expressément recommandée. Tenir hors de portée des jeunes enfants. Non recommandé pendant la grossesse, l’allaitement ni chez les personnes de moins de 18 ans ; s’abstenir d’en consommer dans ces cas sauf indication d’un médecin spécialiste. Les personnes suivant un traitement doivent consulter leur médecin avant de consommer des compléments alimentaires. Conserver dans un endroit frais et sec.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera (L.) Dunal
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    Sources cited by Health Canada (3)
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    Sources cited by Health Canada (3)
    • Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
    • Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.

    Health Canada monograph dated 28 February 2025

  • bêtaglucanes
    Read the warning, when it applies and the studies cited

    BETA-GLUCAN

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Reduction of the severity of symptoms of the common cold.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Bright Naturo

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ashwagandha et crinière de lion (Bright Naturo): composition and regulation”, https://compoatlas.com/en/supplements/products/371442-ashwagandha-et-criniere-de-lion, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line